The MAHA Assessment’s Implications: Drugs (Part One)
FDA Law Blog
JUNE 4, 2025
The Assessment highlights various trends related to chronic disease diagnoses (such as increasing rates of autism spectrum disorder and attention deficit hyperactivity disorder) with associated trends in prescribing practices. We will continue to monitor these developments as they come.
Let's personalize your content